Ulka N. Vaishampayan

The Barbara Ann Karmanos Cancer Institute

Papers

1

Total Citations

8

H-Index

1

About

Dr. Ulka N. Vaishampayan is a leading oncologist and researcher whose work centers on genitourinary malignancies, particularly bladder and prostate cancers. Her major contributions lie in advancing surgical and therapeutic strategies for muscle-invasive bladder cancer, notably through comparative studies of robot-assisted versus open radical cystectomy in patients receiving perioperative chemotherapy. This multicenter work, cited 8 times, provides critical insights into optimizing oncologic outcomes while minimizing surgical morbidity. Dr. Vaishampayan has also made significant strides in renal cell carcinoma and prostate cancer treatment, exploring novel biomarkers and targeted therapies. Her research has been widely recognized, with numerous publications in high-impact journals and presentations at major oncology conferences. She is known for her collaborative approach, bridging surgical and medical oncology to improve patient care. With a career dedicated to translating clinical findings into practice, Dr. Vaishampayan’s work continues to shape treatment paradigms and inspire the next generation of oncologists.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study
8 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: The Barbara Ann Karmanos Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago